All members have the option of attending our various HTC-centric events which include:
Date: Thursday, November 9, 2023
Time: 1:00pm – 2:00pm ET
TITLE:
Learn More About Subcutaneous Prophylaxis Treatment for Hemophilia A: A Discussion on the Latest Data and Patient Management
DESCRIPTION:
Please join us for an engaging webinar led by Ketna Mistry, MD who will be sharing information on patients with hemophilia A with a subcutaneous prophylaxis including the latest clinical data. Ther presentation will include pivotal efficacy and safety data, joint health data, data in infants, and an overview of real-world experience. Be sure to bring your questions to have them answered during the Q&A following the program!
SPEAKER:
Ketna Mistry, MD
Medical Director, Hematology & Rare Blood Disorders, U.S. Medical Affairs; Genentech
Dr. Mistry has 25 years of experience in her medical career, as a physician caring for patients and teacher at Emory University, a researcher at CDC, and currently as a medical director at Genentech. She completed medical school at Tulane University and graduated with honors from UCLA for her bachelor’s degree in psychobiology. She completed her internship and residency in pediatrics at University of Texas in Houston. She is passionate about teaching and sharing information so that patients and providers can make the best informed decision for their care.
